Low-dose aspirin Clinical Trials
3 recruitingDrug
Phase 32Phase 41
Showing 1–3 of 3 trials
Recruiting
Phase 3
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+1 more
University Hospital, Brest1,308 enrolled42 locationsNCT05198960
Recruiting
Phase 4
Treatment With Aspirin After Preeclampsia: TAP Trial
Cardiovascular DiseasesHypertensionPregnancy Complications+8 more
Malamo Countouris60 enrolled1 locationNCT06281665
Recruiting
Phase 3
One-Month DAPT in CABG Patients
Chronic Coronary Disease
Weill Medical College of Cornell University700 enrolled22 locationsNCT05997693